[1]马雯,张昕.工程化外泌体靶向治疗心血管疾病的研究进展[J].国际心血管病杂志,2022,05:289-292.
点击复制
工程化外泌体靶向治疗心血管疾病的研究进展(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2022年05期
- 页码:
- 289-292
- 栏目:
- 综述
- 出版日期:
- 2022-10-01
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2022.05.010
- 文献标识码:
- -
- 摘要:
- 外泌体是具有双层膜结构的小囊泡，可以发挥细胞间通讯的作用，对高血压、冠 状动脉粥样硬化性心脏病、心力衰竭等心血管疾病治疗起重要作用。近年来纳米囊泡工程 技术实现了通过外泌体传递基因信息、药物、核酸，能够提高稳定性，减少不良反应，以达到 心血管疾病靶向治疗的目的。
- Abstract:
- -
参考文献/References
[1] 高润霖, 张澍, 王增武, 等. 新中国成立七十年来我国心血管
病学的发展[J]. 中国循环杂志, 2019, 34(9):833-843.
[2] 高鸿敏, 施冰. 精准医疗在心血管疾病的临床实践[J]. 中国
循证心血管医学杂志, 2017, 9(9):1151-1152.
[3] Pan BT, Johnstone RM. Fate of the transferrin receptor
during maturation of sheep reticulocytes in vitro:selective
externalization of the receptor[J]. Cell, 1983, 33(3):967-978.
[4] Tikhomirov R, Donnell BR, Catapano F, et al. Exosomes: from
potential culprits to new therapeutic promise in the setting of
cardiac fibrosis[J]. Cells, 2020, 9(3):592.
[5] Barani B, Rajasingh S, Rajasingh J. Exosomes: outlook for
future cell-free cardiovascular disease therapy[J]. Adv Exp
Med Biol, 2017, 998(47):285-307.
[6] Wang J, Tang W, Yang M, et al. Inflammatory tumor
microenvironment responsive neutrophil exosomes-based drug
delivery system for targeted glioma therapy[J]. Biomaterials,
2021, 273:120784.
[7] Dong X, Lei Y, Yu Z, et al. Exosome-mediated delivery
of an anti-angiogenic peptide inhibits pathological retinal
angiogenesis[J]. Theranostics, 2021, 11(11):5107-5126.
[8] Usman WM, Pham TC, Kwok YY, et al. Efficient RNA drug
delivery using red blood cell extracellular vesicles[J]. Nat
Commun, 2018, 9(1):2359.
[9] Zhang TR, Huang WQ. Angiogenic exosome-derived
microRNAs: emerging roles in cardiovascular disease[J]. J
Cardiovasc Transl Res, 2021, 14(5):824-840.
[10] Guo D, Xu Y, Ding J, et al. Roles and clinical applications of
exosomes in cardiovascular disease[J]. Biomed Res Int, 2020,
2020:5424281.
[11] Bheri S, Hoffman JR, Park HJ, et al. Biomimetic nanovesicle
design for cardiac tissue repair[J]. Nanomedicine (Lond),
2020, 15(19):1873-1896.
[12] Tong Y, Ye C, Ren XS, et al. Exosome-mediated transfer
of ACE (angiotensin-converting enzyme) from adventitial
fibroblasts of spontaneously hypertensive rats promotes
vascular smooth muscle cell migration[J]. Hypertension, 2018,
72(4):881-888.
[13] Tong Y, Ye C, Zheng F, et al. Extracellular vesicle-mediated
miR135a-5p transfer in hypertensive rat contributes to vascular
smooth muscle cell proliferation via targeting FNDC5[J].
Vascul Pharmacol, 2021, 140:106864.
[14] Ren XS, Tong Y, Qiu Y, et al. MiR155-5p in adventitial
fibroblasts-derived extracellular vesicles inhibits vascular
smooth muscle cell proliferation via suppressing angiotensinconverting
enzyme expression[J]. J Extracell Vesicles, 2019,
9(1):1698795.
[15] Bubb KJ, Tang O, Gentile C, et al. FXYD1 is protective
against vascular dysfunction[J]. Hypertension, 2021,
77(6):2104-2116.
[16] Tong M, Chen Q, James JL, et al. Micro- and nano-vesicles
from first trimester human placentae carry Flt-1 and levels
are increased in severe preeclampsia[J]. Front Endocrinol
(Lausanne), 2017, 8:174.
[17] Chang X, Yao J, He Q, et al. Exosomes from women with
preeclampsia induced vascular dysfunction by delivering
sFlt (soluble Fms-Like tyrosine kinase)-1 and sEng (soluble
endoglin) to endothelial cells[J]. Hypertension, 2018,
72(6):1381-1390.
[18] Perez-Hernandez J, Riffo-Campos AL, Ortega A, et al.
Urinary-and plasma-derived exosomes reveal a distinct
microRNA signature associated with albuminuria in
hypertension[J]. Hypertension, 2021, 77(3):960-971.
[19] Li X, He X, Wang J, et al. The regulation of exosome-derived
miRNA on heterogeneity of macrophages in atherosclerotic
plaques[J]. Front Immunol, 2020, 11:2175.
[20] Niu C, Wang X, Zhao M, et al. Macrophage foam cellderived
extracellular vesicles promote vascular smooth muscle
cell migration and adhesion[J]. J Am Heart Assoc, 2016,
5(10):e004099.
[21] Zheng D, Huo M, Li B, et al. The role of exosomes and
exosomal microRNA in cardiovascular disease[J]. Front Cell
Dev Biol, 2020, 8:616161.
[22] Xing X, Li Z, Yang X, et al. Adipose-derived mesenchymal
stem cells-derived exosome-mediated microRNA-342-5p
protects endothelial cells against atherosclerosis[J]. Aging
(Albany NY), 2020, 12(4):3880-3898.
[23] Shiue SJ, Rau RH, Shiue HS, et al. Mesenchymal stem cell
exosomes as a cell-free therapy for nerve injury-induced pain
in rats[J]. Pain, 2019, 160(1):210-223.
[24] Liu Y, Zhang WL, Gu JJ, et al. Exosome-mediated miR-106a-
3p derived from ox-LDL exposed macrophages accelerated
cell proliferation and repressed cell apoptosis of human vascular smooth muscle cells[J]. Eur Rev Med Pharmacol Sci,
2020, 24(12):7039-7050.
[25] Zhu J, Liu B, Wang Z, et al. Exosomes from nicotinestimulated
macrophages accelerate atherosclerosis
through miR-21-3p/PTEN-mediated VSMC migration and
proliferation[J]. Theranostics, 2019, 9(23):6901-6919.
[26] Chen SJ, Tsui PF, Chuang YP, et al. Carvedilol ameliorates
experimental atherosclerosis by regulating cholesterol efflux
and exosome functions[J]. Int J Mol Sci, 2019, 20(20):5202.
[27] Hosen MR, Goody PR, Zietzer A, et al. MicroRNAs as
master regulators of atherosclerosis: from pathogenesis to
novel therapeutic options[J]. Antioxid Redox Signal, 2020,
33(9):621-644.
[28] Wang L, Liu J, Xu B, et al. Reduced exosome miR-425 and
miR-744 in the plasma represents the progression of fibrosis
and heart failure[J]. Kaohsiung J Med Sci, 2018, 34(11):626-
633.
[29] Zhang Y, Hu YW, Zheng L, et al. Characteristics and roles of
exosomes in cardiovascular disease[J]. DNA Cell Biol, 2017,
36(3):202-211.
备注/Memo
- 备注/Memo:
-
基金项目：研究生科研创新项目（201-202140103）；包头市卫生健
康科技计划项目（wsjkkj001）
通信作者：张昕， E-mail：zhangxinwdq@sina.com
常用功能
统计/Statistics
- 摘要浏览/Viewed4
- 全文下载/Downloads283
- 评论/Comments
